Coverage
-
October 17, 2013
Boston Scientific Corp. will pay $30 million to settle a long-running False Claims Act suit alleging its Guidant LLC unit fleeced Medicare by submitting fraudulent bills for two lines of defective implantable defibrillators, the U.S. Department of Justice said Thursday.
4 other articles on this case.
View all »